Dietary supplementation with Lactobacillus gasseri NT significantly decreased visceral fat weight and triglyceride (TG) in the liver in KK-A y mice on a high-fat diet, but increased fecal TG. A decrease in lipase activity and down regulation of fatty acid transport proteins in the small intestine was involved in fat accumulation by L. gasseri NT.
Dietary supplementation with Lactobacillus gasseri NT significantly decreased visceral fat weight and triglyceride (TG) in the liver in KK-A y mice on a high-fat diet, but increased fecal TG. A decrease in lipase activity and down regulation of fatty acid transport proteins in the small intestine was involved in fat accumulation by L. gasseri NT.
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There are as many as 10 12 CFU bacteria in 1 g of digesta in the human intestine. They constitute a complex microbial community that interacts with host intestinal tissues and have roles not only in nutrition, but also in immunological defense against harmful agents. Thus the intestinal microbial community contributes to nutritional efficiency and the maintenance of host health. 1) In addition to host defense, intestinal tissues secrete several peptide hormones that influence the movement of the digestive tract as well as the appetite of the host. The intestinal microbial community can attenuate host nutrition by modification of hormone secretion.
2) The connection between gut microbiota and the energy homeostasis of the host is increasingly recognized. For example, dietary modulation of gut microbiota to increase the bifidobacterial population significantly reduced endotoxemia and improved glucose tolerance in one study.
3) This modulation also alleviates inflammation in mice fed a high fat diet.
3) In addition to glucose metabolism, some preliminary studies have indicated the importance of gut microbiota in the lipid metabolism of the host. 4) In this context, prebiotics and probiotics, which are recognized as intestinal flora modifiers, attract attention from those working on weight control and obesity prevention. In our previous study, we confirmed that administration of L. gasseri NT reduced periovarian fat and serum-free fatty acid (FFA) in BALB/c mice fed a high-fat diet. These effects were induced by repression of fat synthesis, 5) but the mechanisms by which probiotics affect lipid metabolism must evaluated, because BALB/c mice do not consume an excessively high-fat diet, which means that they are not good models for obesity due to excessive food consumption. Accordingly, we conducted a study using KK-A y mice, a model for diabetes characterized by hyperphagia, hyperglycemia, hyperinsulinemia, and insulin resistance. 6) In the present experiment, we evaluated the effects of a probiotic, L. gasseri NT, on lipid digestion and metabolism in KK-A y mice by a pair-feeding approach. The reason for pair feeding was to eliminate the effect of L. gasseri NT on food consumption. The experiments were approved by the Animal Experiment Committee of Kyoto Prefectural University. Chemicals were purchased from Nacalai Tesque (Kyoto, Japan) unless otherwise stated. 45 kcal%Fat diet, D12451 was purchased from Research Diets, Inc. (New Brunswick, NJ). Four-week-old male KK-A y mice were purchased from CLEA Japan (Tokyo). They were kept in individual cages in a room kept at 25 AE 1 C under a 12-h light and dark cycle. They were divided into the following groups: HFD (eight mice fed a 45 kcal%Fat diet, D12451, 4.73 kcal/g) and HFD þ Lg (eight mice fed D12451 supplemented with freeze-dried L. gasseri NT at 10 9 CFU/g, 4.73 kcal/g). The energy intake of the mice was adjusted by pair feeding for 5 weeks. Thus the food intake and total calorie intake levels of the groups were nearly the same. Average daily food intakes were 4:79 AE 0:40 g and 4:73 AE 0:28 g, and total calorie intakes were 725 AE 60 kcal and 716 AE 42 kcal for the HFD and HFD þ Lg groups respectively. The levels were slightly lower than consumption in ad libitum feeding (about 5 g for KK-A y mice at 40 g of body weight). Body weight was measured daily. At the end of the experiment, the mice were dissected under general anesthesia to remove periovarian fat and the liver. The periovarian fat was considered to represent visceral adipose tissue. After removal, a portion (about 500 mg) of the periovarian fat was collected in RNAlater Ò Solution (Sigma, Tokyo, Japan) for mRNA analysis. A portion (about 500 mg) of the liver was also collected in RNAlater Ò Solution for mRNA analysis. These subsamples were stored at À30 C after overnight fixation in RNAlater Ò . The other portion (about 500 mg) of the liver was freeze-dried for lipid extraction. The entire intestine was removed, and the distal portion of the ileum, 1 cm from the ileocecal valve, was collected in RNAlater Ò Solution for mRNA analysis. At the same time, the entire ileal digesta were collected and immediately stored at À30
C. Blood samples were collected from the inferior vena cava.
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7 ) The expression levels of the target genes were determined by the real-time PCR approach by the use of LightCycler Ò 480 (Roche Applied Science, Tokyo). PCR was performed with a thermal cycle program with initial denaturation at 95 C for 5 min, followed by 50 cycles of 95 C for 10 s and 60 C for 20 s. In this analysis, the -actin gene was used as housekeeping gene. The target genes with their GenBank accession numbers were as follows: -actin (GenBank accession no. NM007393), Cholesterol 7-hydroxylase (CYP7) (GenBank accession no. NM007824.2), Monocyte chemo-attractant protein 1 (MCP-1, CCL2) (GenBank accession no. NM011333), Fatty acid transport protein 2 (FATP2, Slc27a2) (GenBank accession no. NM011978.2), and Fatty acid transport protein 4 (FATP4, Slc27a4) (GenBank accession no. NM011989.4). The primers and probes used in this study were designed by means of software (https://www.roche-applied-science.com/). Delta Ct was calculated by subtracting the crossing point cycle of the housekeeping gene (-actin) from those of the other genes analyzed. All data for mRNA expression are presented as the ratio of the level for HFD þ Lg relative to that of the control, HFD. Extraction of total lipids from the freeze-dried liver and feces was carried out by a standard method. 8) Briefly, portions of the liver (about 30 mg) or feces (about 10 mg) were extracted by chloroform-methanol solution. The total lipids of the extracts were measured as constant weight after evaporation of the solvent. The TG concentration in the extract resolved by 2-propanol (1 mL) was further determined by TG E-Test. Determination of bile acid concentrations in the feces and digesta was carried out as reported by Higaki et al. (2006) . 9) Determination of the lipase activity of the ileal digesta was carried out by means of Lipase Kit S (DS Pharma Biomedical, Osaka, Japan). The digesta were diluted 40-hold with distilled water before analysis. Activities were expressed as values relative to that of 10 U/mL of porcine pancreatic lipase. Student's t-test was done after the F-test, which confirmed homoscedasticity. Statistical analyses were done with Excel Toukei 2010 (Social Survey Research Information, Tokyo).
The body weight of mice was nearly the same for the HFD and HFD þ Lg groups throughout the experiment, but the weight (g) and the relative weight (% of body weight) of the periovarian (p < 0:01) fat and the liver (p < 0:05) were both significantly lower in the HFD þ Lg group than in the HFD group. In addition, total lipids and TG in the liver were significantly lower in the HFD þ Lg group than in the HFD group (p < 0:01) ( Table 1) .
There was no significant difference in serum TG levels between the two groups, but the HFD þ Lg mice showed significantly lower T-cho (p < 0:01), FFA (p < 0:05), and glucose (p < 0:05) than the HFD mice ( Table 1 ). The HFD þ Lg mice showed significantly higher fecal TG and ileal bile acid than the HFD mice (p < 0:05) ( Table 1) .
The HFD þ Lg mice showed higher relative expression of CYP7 mRNA in the liver than the HFD mice (p < 0:05), but the HFD þ Lg mice showed lower periovarian fat MCP-1 mRNA expression and jejunal FATP2 and FATP4 mRNA than the HFD mice (p < 0:05) (Fig. 1) .
The relative lipase activity of the ileal digesta was lower in the HFD þ Lg group than in the HFD group (p < 0:05) (Fig. 2) . In this experiment, oral administration of L. gasseri NT significantly increased the fecal TG concentration, which suggests that lipid digestion and/or absorption was repressed by feeding of L. gasseri NT. Decreased lipid absorption might explain the observed reduction in visceral fat weight and blood FFA, in that ileal lipase activity decreased 10% and mRNA expression of fatty acid transport proteins in the small intestine was down regulated by feeding of L. gasseri NT. Significantly lower serum cholesterol confirms reduced lipid digestion and/or absorption in the small intestine.
Recently, Matsumura 10) reported that L. gasseri NLB367 inhibited pancreatic lipase in vitro, though he did not describe in detail the mechanisms of inhibition. There are several possible mechanisms for lactobacillal inhibition of lipase: that L. gasseri NLB367 reacts directly with lipase to prevent lipase from binding with its substrate, or that L. gasseri NLB367 inhibits micelle formation. Matsumura stressed in his report that a wide variety of lactobacilli inhibit lipase. Accordingly, it is plausible that its inhibitory effect on lipase is not species-or strain-specific. The latter possibility, inhibition of micelle formation, is more plausible as an inhibitory mechanism.
On the other hand, the bile acid concentration of the ileal digesta increased. Indeed, the color of the ileal digesta changed visually, becoming redder. It is interesting to consider why the bile acid concentration was elevated when the lipase activity was decreased by feeding of L. gasseri NT. Increased hepatic expression of CYP7 mRNA can explain the increased bile acid concentration in the small intestinal digesta, because Cholesterol 7-hydroxylase, CYP7, is the enzyme that catalyzes the synthesis of bile acid from cholesterol. In considering the fecal bile acid concentration, which did not differ between the groups of animals, the size of the bile acid pool should have increased in the jejunum and the ileum. If micelle formation was significantly inhibited by L. gasseri NT under the high-fat diet, more bile acid might be secreted to support fat digestion and absorption. Inhibition of micelle formation occurs when bile acid is absorbed by hydrophobic materials such as soy peptide.
11) A range of lactic acid bacteria absorb and retain bile acids within the cells, 12, 13) which can inhibit the micelle formation. Moreover, the solubility of bile acid can be affected indirectly by L. gasseri NT, because bile acids become insoluble when the intestinal pH is lower than 6.5. If the pH condition in the intestine becomes low due to acids produced by lactic acid bacteria, bile acid becomes inactive as to forming micelles. 14) Lowered lipase activity might also explain the increase in bile acid pool in the small intestine. This is consistent with the finding that the administration of chitosan, which inhibits pancreatic lipase activity, induced bile acid excretion in a rat model. 15) A negative correlation has been found between the LDL-cholesterol concentration in the blood and bile acids in the intestine. 16) A reduction in bile acid biosynthesis might increase hepatic cholesterol and oxysterol levels, which should influence the function of the lipogenic SREBP-1c by attenuating processing and activation of it. 17) SREBPs, membrane-bound transcription factors, regulate lipid homeostasis by controlling enzymes such as fatty acid synthase (FAS). Indeed, overexpression of nSREBP-1c in the liver produces a triglyceride-enriched fatty liver. 18) This might decrease hepatic TG production.
At the transcriptional level, bile acids, which are endogenous ligands of the hepatic farnesoid X receptor (FXR), activate the transcription of several hepatic genes that can modulate TG levels, such as the atypical nuclear receptor small heterodimer partner 19) (SHP) and PPAR. 20) PPAR-is a nuclear receptor that regulates hepatic lipid metabolism by up regulating carnitine palmitoyl transferase 1 (CPT-1), which oxidizes fatty acids. 21) Since bile acids have many regulatory functions in lipid metabolism, the effect of L. gasseri NT on lipid metabolism may be elicited by induction of bile acid secretion. This aspect should be examined in further studies. The serum bile acid could not be determined in this experiment due to the blood sample's limited quantity. Moreover, not all feces were collected in this experiment. The limited fecal sample also limited our discussion of the bile acid balance. Additional study that focuses on bile acid metabolism should be considered.
In conclusion, oral administration of L. gasseri NT decreased visceral fat weight through inhibition of lipase and, perhaps, reduction of bile acid activity in the intestine. , HFD þ Lg. Ã p < 0:05.
